Differentiating Guillain-Barré syndrome from other diseases: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Guillain-Barré syndrome}} | {{Guillain-Barré syndrome}} | ||
{{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh13579@gmail.com] | {{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, MBBS]] [mailto:psingh13579@gmail.com] | ||
Revision as of 20:23, 20 June 2016
Guillain-Barré syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Differentiating Guillain-Barré syndrome from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating Guillain-Barré syndrome from other diseases |
FDA on Differentiating Guillain-Barré syndrome from other diseases |
CDC on Differentiating Guillain-Barré syndrome from other diseases |
Differentiating Guillain-Barré syndrome from other diseases in the news |
Blogs on Differentiating Guillain-Barré syndrome from other diseases |
Risk calculators and risk factors for Differentiating Guillain-Barré syndrome from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, MBBS [2]
Overview
Guillain-Barré syndrome is an acute, autoimmune, polyradiculoneuropathy affecting the peripheral nervous system, usually triggered by an acute infectious process. It is included in the wider group of peripheral neuropathies.